A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 53, Issue SUPPL., 1999, Pages

  Ito, Chihiro ^a   Kubota, Yasuhiko ^a   Sato, Mitsumoto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Polypharmacy; Psychopharmacology algorithm; Treatment of schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BIPERIDEN; BROMPERIDOL; CHLORPROMAZINE; DIAZEPAM; EMONAPRIDE; ETIZOLAM; FLUNITRAZEPAM; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; LEVOMEPROMAZINE; NITRAZEPAM; PERICIAZINE; PROMETHAZINE; RISPERIDONE; SULPIRIDE; TRANQUILIZER; TRIHEXYPHENIDYL; ZOTEPINE;

ADULT; CONFERENCE PAPER; DRUG CHOICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PROSPECTIVE STUDY; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; SCHIZOPHRENIA;

ADULT; ALGORITHMS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; JAPAN; MALE; PATIENT ADMISSION; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032747256     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Davis JM, Schaeffer CB, Killian GA et al. Important issues in the drug treatment of schizophrenia. Schizophr. Bull. 1980; 6: 70-87.
2. Tateyama B, Koshigawa H, Tkuno M. Present status of prescription of antipsychotic drugs. Seishin Igaku Rev. 1993; 6: 14-26 (in Japanese).
3. Kawakami F, Nakajima T, Koyama T et al. Investigation of the state of polypharmacy in psychiatric drug therapy. Jpn J. Psychiatr. Treat. 1997; 12: 795-803 (in Japanese).
4. Clark AF, Holden NL. The persistence of prescribing habits: A survey and follow-up prescribing to chronic in-patients. Br. J. Psychiatry 1984; 150: 88-91.
5. Johnson DAW, Wright N. Drug prescribing to schizophrenic outpatients on depot injection: Repeat surveys over eighteen years. Br. J. Psychiatry 1990; 156: 827-834.
6. Itoh H, Fujii Y. Psychotropic polypharmacy in Japan: Its present status and controversy on its merits and/or demerits. Jpn J. Neuropsychopharmacol. 1983; 5: 149-184 (in Japanese).
7. Rosholm JU, Hallas J, Gram LF. Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients: A prescription database study. Br. J. Clin. Pharmacol. 1994; 37: 533-538.
8. Sato M. Algorithm for schizophrenia in Japan. Psychopharmacol. Bull. 1995; 31: 501-504.
9. Zarate Jr CA, Daniel DG, Kinon BJ et al. Algorithms for the treatment of schizophrenia. Psychopharmacol. Bull. 1995; 31: 461-467.
10. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. Am. J. Psychiatry 1997; 154 (Suppl. 4): 1-63.
11. Frances A, Docherty JP, Kahn DA. The expert consensus guideline series: Treatment of schizophrenia. J. Clin. Psychiatry 1996; 57 (Suppl. 12B): 1-50.